Search is Powered by Google
Prostate / Prostate Cancer News

Why Men In The United Kingdom Still Want The Prostate Specific Antigen Test

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Men's health
Article Date: 02 Mar 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

UroToday.com - In a report in the January 2008 issue of Qualitative Health Research, an Oxford University team of sociologists led by Alison Chapple analyzed British men's views and experiences regarding PSA screening. The UK has no formal national screening program for prostate cancer (CaP) but in 2001 the UK Department of Health introduced the Prostate Cancer Risk Management Program (PCRMP), which gives men access to the PSA test if they are first informed about its benefits and limitations. All general practitioners in UK received information about the PCRMP. The authors who have previously reported on British men's views on heath screening sought to explore men's views since the PCRMP was introduced.

The objectives of the research was to explore men's understanding of the PSA test, their perceptions of the information they received, the factors that they said influenced them when deciding whether to have a test, and their understanding of the results. The analysis included 30 men who underwent 1-2 hour interviews in their homes. Participant range was ages 40-78, almost all were white and most were recruited via their general practitioner

. Overall, the views were similar to those noted prior to the introduction of the PCRMP. Most men described having been given little information and encouraged by wives, friends, and the media to have the test. Three aspects dominated the views of the men interviewed; that PSA is perceived and approached by men and doctors as "just another blood test", that any testing for cancer is responsible health behavior, and that there is a lack of communication about the uncertainty that is inherent in the test and treatment options. Some men viewed PSA screening as civic duty to advance medical science, others as prevention is better than cure. Overall however, men interviewed were still unsure about the meaning of the PSA test and received little information from their general practitioners. Men often seemed unprepared for the possible adverse consequences of having the test, including the uncertainties about the value of treatment.

Chapple A, Ziebland S, Hewitson P, McPherson A

Qual Health Res. 18(1): 56-64, January 2008
DOI: 10.1177/1049732307309000

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS Professor & Chairman Department of Urology University of California, Davis, School of Medicine Sacramento, CA

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...